Articles published by One Biosciences

New Research from One Biosciences Shows Single-Cell Profiling Can Identify Which Ovarian Cancer Tumors are Predisposed to Chemotherapy Resistance

October 20, 2026

From One Biosciences

Via Business Wire

One Biosciences Receives €3,3 Million Funding Under i-Démo 5 From France 2030 to Accelerate Development of First Single-Cell Diagnostic for Triple-Negative Breast Cancer, in Collaboration With Institut Curie

September 10, 2026

From One Biosciences

Via Business Wire

One Biosciences Announces Data Validating New Method for Single-Cell Transcriptomic Tumor Profiling from Clinical Pathology Samples

July 30, 2026

From One Biosciences

Via Business Wire

One Biosciences Receives BOOST Funding From Paris-Saclay Cancer Cluster to Advance the First Single-Cell Assay Approach for ADC Therapies

June 22, 2026

From One Biosciences

Via Business Wire

Gustave Roussy and One Biosciences Partner to Bring Single Cell to Clinical Practice for Precision Oncology

May 19, 2026

From One Biosciences

Via Business Wire

One Biosciences’ Single Cell Data Mining Algorithm “MAYA” Featured in Nature Communications

April 06, 2023

From One Biosciences

Via Business Wire

One Biosciences Initiates LARYCARE Clinical Study, Its Second Discovery Program

September 13, 2022

From One Biosciences

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.